Top Medical News
Pearl Toh, 3 hours ago
The LAMA* aclidinium bromide was similarly effective in reducing exacerbation rate without raising the risk of MACE** or all-cause mortality regardless of recent history of exacerbations in patients with moderate-to-very severe chronic obstructive pulmonary disease (COPD), according to a subgroup analysis of the phase IV ASCENT-COPD*** trial presented at the CHEST 2019 Annual Meeting.
4 hours ago
The use of statins is beneficial in elderly patients after their first myocardial infarction (MI) episode, particularly if medication is sustained for at least 2 years, a recent study has shown.
Elvira Manzano, 8 hours ago
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Roshini Claire Anthony, 8 hours ago

The addition of pertuzumab to a trastuzumab-docetaxel regimen in the neoadjuvant setting improved total pathological complete response (tpCR) rates in Asian women with early or locally advanced ERBB2-positive breast cancer, according to the phase III PEONY trial from China.

8 hours ago
Younger men with prostate cancer tend to experience greater psychological distress, a new study has found.
9 hours ago
Use of the feminizing hormone therapy medroxyprogesterone acetate (MPA) results in minimal side effects, unchanged oestradiol levels and a decline in testosterone in a cohort of transwomen, a study has found.
Jairia Dela Cruz, 9 hours ago
Showing patients a short video about coronary angiography or angioplasty helps improve knowledge about the procedure and consequently alleviate their anxiety, according to a study presented at the European Society of Cardiology (ESC) Asia Congress 2019 with Asian Pacific Society of Cardiology (APSC) and the Asean Federation of Cardiology (AFC).
Special Reports
06 Nov 2019
Pertussis is a highly contagious respiratory illness caused by Bordetella pertussis. Despite the introduction of effective infant immunisation programmes and high vaccination coverage, pertussis remains a public health concern.1 Recently, MIMS Doctor spoke to Dato’ Dr Musa Mohd Nordin who gave us some insights into the resurgence of pertussis in Malaysia, highlighting strategies to further strengthen the current vaccine coverage rate (VCR).
05 Nov 2019
At the A. Menarini-sponsored symposium, held during the 8thAssociation of South-East Asian Pain Societies (ASEAPS)Congress at Pullman Hotel Kuching, Malaysia, the importance ofa multidisciplinary approach in the management of osteoarthritis(OA) was discussed. A distinguished panel of speakers reviewedthe role of various types of treatments in the management of OAthrough a hypothetical patient case scenario, and shared theirinsights into some questions commonly asked by physicians,including their recommended strategies for pre- and postsurgeryanaesthesia and analgesia
05 Nov 2019
Influenza infection is often times underrecognised and underdiagnosed in Malaysia even though it may occur at anytime of the year, unlike in temperate countries. Smoking is a well-established  risk factor for influenza infection, and it is associated with a more severe disease course, morbidity and mortality. The National Avian Influenza Surveillance System of Thailand reported that current or former smoking is among the risk factors associated with a fatal outcome in patients with influenza.
22 Oct 2019
Invasive meningococcal disease is a life-threatening bacterial infection caused by Neisseria meningitidis that can progress rapidly and cause permanent disability.
22 Oct 2019
Topical silicone gel is considered first-line therapy against scars and is used particularly for the treatment of elevated scars,such as hypertrophic and keloid scars. In this report, Dr Yong shares his clinical experience of using silicone gel as part of his scar management strategies.
22 Oct 2019
Jointly organized by the Malaysian Medical Associationand AstraZeneca to commemorate the launch of QTERN,the Q-UEST Symposium saw three distinguished speakersproviding valuable insights into the landscape of T2DMin Malaysia and discussing the latest treatment optionsavailable in the country.
03 Oct 2019
Annual inactivated influenza vaccination is recommendedfor children with chronic asthma owing to its role indecreasing the severity of disease, complications andsecondary infections. In a resource-limited setting, thissegment of patients should be prioritized to receiveinfluenza vaccinations.
Conference Reports
Elvira Manzano, 12 Nov 2019
Supplementation with omega-3 fatty acids or vitamin D3 for up to 5 years has no effect on kidney function in adults with type 2 diabetes (T2D), the VITAL-DKD* ancillary study has shown.
Stephen Padilla, 12 Nov 2019
Mindfulness-based interventions (MBIs) are beneficial for patients with coronary heart disease (CHD) in reducing perceived stress, depression and anxiety, as shown by evidence in a systematic review, which was presented at the recent European Society of Cardiology (ESC) Asia Congress 2019 in Singapore.
Pearl Toh, 31 Oct 2019
Treatment with the selective PARP* 1/2 inhibitor niraparib after a response to first-line platinum-based chemotherapy significantly extends progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer, including those at high risk of relapse, according to the PRIMA** study presented at ESMO 2019.
Roshini Claire Anthony, 31 Oct 2019

Upfront combination therapy with metformin and the DPP-4* inhibitor vildagliptin may improve glycaemic durability in patients newly diagnosed with type 2 diabetes (T2D) compared with sequential therapy with metformin monotherapy followed by vildagliptin, results from the VERIFY** trial showed.

Elvira Manzano, 29 Oct 2019
The 30-day mortality rates among patients undergoing transcatheter aortic valve replacement (TAVR) have decreased by more than half over the last decade, with significant differences between genders, a CENTER* collaboration analysis has shown.
Pearl Toh, 26 Oct 2019
Adding the PD-L1 inhibitor atezolizumab to first-line platinum-based chemotherapy significantly prolonged progression-free survival (PFS) compared with chemotherapy alone in patients with metastatic urothelial carcinoma (mUC), according to the IMvigor130* study presented at the ESMO Congress 2019.
Audrey Abella, 25 Oct 2019
The novel dual GIP* and GLP-1** receptor agonist tirzepatide demonstrated clinically meaningful improvements in glycaemic control and weight loss in patients with type 2 diabetes (T2D), according to data presented at EASD 2019.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download